Partners

Distribution partnership open territories

The NiTi Brush is supplied through authorised distributors in 18 countries. We are open to partners in territories we do not yet cover, and to established dental distributors who want to add a peri-implantitis instrument with an independent evidence base behind it.

15Years in production
16Verified publications
67Independent investigators
33Institutions in 14 countries
18Countries supplied

What we provide

Regulatory documentation

EC certificate, Declaration of Conformity, GMDN classification, EU authorised representative and manufacturer SRN, and the FDA listing record — supplied in full for your own registration work.

Instructions for Use in 19 languages

Print-ready IFU in Czech, Danish, Dutch, English, Estonian, Finnish, French, German, Croatian, Hungarian, Italian, Latvian, Lithuanian, Polish, Romanian, Slovak, Slovenian, Spanish and Swedish.

Clinical and scientific material

The published literature, clinical case documentation, SEM imagery and the treatment protocol — the material your team needs to present the instrument to clinicians.

Product training

Protocol training for your sales team and for clinicians: model selection, drive and speed, sterilisation, and the surgical sequence around the debridement step.

Marketing assets

Brochure, leaflet and catalogue files, product photography and clinical imagery, licensed for your use in the territory.

Direct line to the manufacturer

HANS Korea manufactures the instrument itself. Technical questions, complaint handling and vigilance reporting go straight to the people who make it.

Commercial terms

Terms are set per territory and are provided on enquiry. We do not publish them, because volume, exclusivity and the registration work required differ considerably between markets.

Minimum order quantity Provided on enquiry — set with the first order and reviewed annually
Pricing and margin Distributor price list provided on enquiry, by territory and volume band
Lead time Confirmed at quotation, against current production scheduling
Territory and exclusivity Negotiable. Exclusivity is normally tied to agreed volume and to registration being completed in the territory
Product range POCKET · POCKET SHORT · NANO · OMEGA — see the line-up
Shelf life 5 years from the date of manufacture
Regulatory status CE Class IIa; MDR transition under way — see the timeline

How it works

  1. Enquiry

    Tell us your territory, the segment you sell into and your current implant portfolio.

  2. Terms and samples

    We send the price list, order terms and the regulatory pack, and arrange samples for evaluation.

  3. Registration

    We supply the documentation you need for registration in your market and answer the authority's questions directly.

  4. Launch

    Product training for your team, marketing assets, and a first order scheduled against production.

Partnership, licensing and investment

Beyond distribution, HANS Korea is open to conversations about manufacturing and licensing agreements, OEM supply, co-development, and corporate transactions.

Write to [email protected] with “Partnership” in the subject line. Such enquiries are read by the company's management and handled in confidence; a non-disclosure agreement can be put in place before any detail is exchanged.

Available under NDA

  • Company financials and production volumes.
  • Full regulatory documentation, including the MDR transition file and notified body correspondence.
  • Intellectual property records — granted patents, utility model and registration certificates.
  • Distribution agreements and territory performance.
  • Manufacturing capacity, tooling and the facility commissioned for MDR-conformant production.
Confidential enquiries [email protected]
Please put “Partnership” in the subject line.
CompanyHANS KOREA CO.,Ltd.
Telephone+82-31-977-2809
Address 314Ho, 107 Garam-ro 116beon-gil, Paju-si, Gyeonggi-do 10896, Republic of Korea

Nothing on this page is an offer or an invitation to invest. It describes the basis on which we are willing to open a confidential discussion.